immunAware ApS: Financial statements 2023
CVR: 39189135
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
immunAware ApS (CVR 39189135) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 5,438,301 and a net result of DKK 1,308,604 compared with DKK 1,567,432 the year before. That is an increase of 6.7% compared with the year before. Equity in the 2023 report amounted to DKK 6,169,596. The solvency ratio was 86.6%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 5,438,301
- Profit/Loss
- DKK 1,308,604
- Equity
- DKK 6,169,596
- Total Assets
- DKK 7,120,285
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 5.4 mio. | 1.3 mio. | 6.2 mio. | 6 |
| 2022 | - | 5.1 mio. | 1.6 mio. | 5 mio. | 5 |
| 2021 | - | 3.4 mio. | 1.2 mio. | 3.6 mio. | 3 |
| 2020 | - | 2.4 mio. | 1.2 mio. | 2.6 mio. | 1 |
| 2019 | - | 2.3 mio. | 1.4 mio. | 1.5 mio. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ImmunAware ApS has published its annual report for 2022. Gross profit came to DKK 5,094,846, and the net result was DKK 1,567,432.
As of June 9, 2023, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of immunAware ApS.
About immunAware ApS
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.